OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference | |
---|---|
Date : 2022-03-22 View : 988 | |
OliX Pharmaceuticals to Present at SMi 13th Annual RNA Therapeutics Conference
Suwon, Republic of Korea, February 07,
2022 (GLOBE NEWSWIRE) – OliX
Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer
of RNAi therapeutics, today announced that the Company’s management will present
at the SMi 13th Annual RNA Therapeutics
Conference taking place virtually February 9-10, 2022.
Dong Ki Lee, Ph.D., Founder and Chief Executive Officer of OliX, will
deliver an opening address focused on the company’s proprietary asymmetric
siRNA technology and pipeline programs, including OLX104C for hair loss, OLX301A
for wet/dry age-related macular degeneration (AMD), OLX702A for non-alcoholic
steatohepatitis (NASH), and OLX703A for hepatitis B virus (HBV).
Details for the upcoming presentation are below:
SMi 13th Annual RNA Therapeutics Conference
### |
|
Prev | OliX Pharmaceuticals Presents Potential Utility of GalNAc-asiRNA Platform at OPT Congress |
Next | OliX Pharmaceuticals to Participate in BIO Partnering at JPM and Biotech Showcase 2022 Conferences |
- Home
- PR